Deferred Tax Assets, Valuation Allowance of PharmaCyte Biotech, Inc. from 30 Apr 2012 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PharmaCyte Biotech, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Apr 2012 to 30 Apr 2025.
  • PharmaCyte Biotech, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Apr 2025 was $15,221,718, a 0.18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $15,221,718 +$27,998 +0.18% 30 Apr 2025 10-K 11 Aug 2025 2025 FY
Q1 2024 $15,193,720 -$1,035,621 -6.4% 30 Apr 2024 10-K 11 Aug 2025 2025 FY
Q1 2023 $16,229,341 +$470,940 +3% 30 Apr 2023 10-K 13 Aug 2024 2024 FY
Q1 2022 $15,758,401 -$739,798 -4.5% 30 Apr 2022 10-K 31 Jul 2023 2023 FY
Q1 2021 $16,498,199 +$969,241 +6.2% 30 Apr 2021 10-K 31 Jul 2023 2023 FY
Q1 2020 $15,528,958 +$1,341,187 +9.5% 30 Apr 2020 10-K 28 Jul 2022 2022 FY
Q1 2019 $14,187,771 +$952,170 +7.2% 30 Apr 2019 10-K 10 Aug 2021 2021 FY
Q1 2018 $13,235,601 30 Apr 2018 10-K 13 Aug 2020 2020 FY
Q1 2014 $12,821,094 +$364,071 +2.9% 30 Apr 2014 10-K 04 Aug 2014 2014 FY
Q1 2013 $12,457,023 +$256,694 +2.1% 30 Apr 2013 10-K 04 Aug 2014 2014 FY
Q1 2012 $12,200,329 30 Apr 2012 10-K 29 Jul 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.